PARIS (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose ...

(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, Chief Executive Officer Pascal Soriot told the ...

Healthcare giants Pfizer Inc (NASDAQ:PFE) and AstraZeneca Plc (NASDAQ:AZN) have investments in France, collectively totaling around $1 billion, bolstering the country’s healthcare sector. Pfizer ...

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines ...

PARIS (Reuters) - French health authorities see no reason to suspend the use of AstraZeneca COVID-19 vaccinations, despite suspensions in some other European countries, French Health Minister Olivier ...

AstraZeneca Plc (NASDAQ:AZN) is reportedly reconsidering its planned $578.4 million (450 million pounds) investment in a new vaccine-manufacturing site, a departure from CEO Pascal Soriot‘s previous ...

For the best experience, please enable JavaScript in your browser settings. Josphine Moraa, a nurse at Kisii Teaching and Referral Hospital, prepares a Covid-19 ...

AstraZeneca's camizestrant in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (palbociclib, ribociclib or abemaciclib) has been ...

Sir Pascal Soriot is one of the most consequential pharmaceutical executives in history. He is a French-born Australian businessman who took over a British-Swedish pharma giant in crisis, rebuilt it ...